NYSE · CIK 0001964738 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SOLVENTUM CORPORATION
SOLV chart by TradingView
PRICE HISTORY
LIVE · NYSESOLV chart by TradingView
- REVENUE FY2025 ENDED DEC 2025
- $8.3B
- EBITDA
- $2.7B
- FREE CASH FLOW
- $-0.0B
- EPS
- $8.88
- GROSS MARGIN
- 53.47%
- ROIC
- 16.90%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 14 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET
VALUATION
what you pay for a unit of the business7 CHARTS⤢
P / E RATIO (TTM)
9.3x
+0%8.0x35.1x
⤢
P / SALES (TTM)
1.6x
+10%1.1x1.7x
⤢
P / BOOK
2.8x
-11%2.3x4.1x
⤢
EV / EBITDA (TTM)
7.0x
-18%6.0x15.7x
⤢
EV / REVENUE (TTM)
2.2x
-8%1.9x2.5x
⤢
FCF YIELD (TTM)
-0.88%
-13.5pp-1.77%16.60%
⤢
DIVIDEND YIELD (TTM)
—
GROWTH
is the business getting bigger5 CHARTS⤢
REVENUE
$2.2B
+10%⤢
EBITDA (DERIVED)
$0.3B
-40%⤢
NET INCOME
$0.1B
-69%⤢
EPS (DILUTED)
$0.53
-69%⤢
REVENUE GROWTH YOY
2.22%
+2.0pp-3.71%3.84%
PROFITABILITY & RETURNS
what survives to the bottom, and what it earns on capital4 CHARTS⤢
FCF MARGIN
6.52%
-15.6pp-13.60%22.54%
⤢
RETURN ON CAPITAL
15.13%
+3.6pp3.46%17.97%
⤢
RETURN ON EQUITY (TTM)
29.88%
+18.3pp10.43%36.90%
MARGIN FUNNEL
every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the businessGROSS MARGIN58.22%
OPERATING MARGIN8.19%
NET MARGIN4.16%
FCF MARGIN6.52%
CASH & CAPITAL
where the money actually goes5 CHARTS⤢
FREE CASH FLOW
$0.1B
-68%⤢
STOCK-BASED COMP
$0.0B
+111%⤢
CAPITAL EXPENDITURE
$0.1B
+28%⤢
SHARES OUTSTANDING
0.17B
+0%⤢
DIVIDEND / SHARE
—
BALANCE SHEET
how much cushion there is3 CHARTS⤢
CASH & EQUIVALENTS
$0.4B
+108%⤢
TOTAL DEBT
$5.1B
-39%⤢
DEBT / EBITDA (TTM)
2.0x
-46%1.9x6.0x
OWNERSHIP
10 LARGEST HOLDERS · WHO OWNS THE FLOATINSTITUTIONS 75.87%INSIDERS 15.33%OTHER / RETAIL 8.81%1,158 INSTITUTIONAL FILERS
| HOLDER | % HELD | SHARES | VALUE | CHANGE |
|---|---|---|---|---|
| Independent Franchise Partners, LLP | 9.24% | 15.7M | $1.31B | +2.5% |
| Blackrock Inc. | 6.16% | 10.5M | $869.5M | +1.7% |
| Vanguard Capital Management LLC | 5.64% | 9.6M | $796.8M | NEW |
| Trian Fund Management, LP | 4.84% | 8.2M | $683.5M | +0.0% |
| State Street Corporation | 3.76% | 6.4M | $531.7M | +1.0% |
| Vanguard Portfolio Management LLC | 3.75% | 6.4M | $530.3M | NEW |
| Davis Selected Advisers | 3.72% | 6.3M | $525.3M | +1.8% |
| Geode Capital Management, LLC | 2.79% | 4.8M | $394.3M | +3.6% |
| Boston Partners | 2.37% | 4.0M | $335.1M | +3.2% |
| Invesco Ltd. | 2.23% | 3.8M | $314.5M | +29.3% |
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.